FinTrust Capital Advisors LLC lifted its stake in Cerner Co. (NASDAQ:CERN) by 6,480.6% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 8,160 shares of the company’s stock after buying an additional 8,036 shares during the period. FinTrust Capital Advisors LLC’s holdings in Cerner were worth $598,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors also recently modified their holdings of CERN. Nelson Roberts Investment Advisors LLC purchased a new stake in shares of Cerner in the first quarter worth about $25,000. Berman Capital Advisors LLC lifted its stake in shares of Cerner by 115.3% in the second quarter. Berman Capital Advisors LLC now owns 381 shares of the company’s stock worth $27,000 after acquiring an additional 204 shares in the last quarter. Advisory Alpha LLC acquired a new position in shares of Cerner in the first quarter worth about $28,000. Creative Financial Designs Inc. ADV lifted its stake in shares of Cerner by 303.4% in the first quarter. Creative Financial Designs Inc. ADV now owns 710 shares of the company’s stock worth $41,000 after acquiring an additional 534 shares in the last quarter. Finally, Valeo Financial Advisors LLC acquired a new position in shares of Cerner in the second quarter worth about $49,000. 82.59% of the stock is owned by institutional investors.
Several research analysts recently commented on CERN shares. BidaskClub cut Cerner from a “hold” rating to a “sell” rating in a research note on Thursday, July 25th. Bank of America boosted their price target on Cerner from $70.00 to $77.00 and gave the stock a “buy” rating in a research note on Tuesday, May 21st. Piper Jaffray Companies boosted their price target on Cerner from $74.00 to $80.00 and gave the stock an “overweight” rating in a research note on Thursday, July 25th. ValuEngine upgraded Cerner from a “hold” rating to a “buy” rating in a research note on Wednesday, May 1st. Finally, Cantor Fitzgerald boosted their price target on Cerner from $75.00 to $85.00 and gave the stock an “overweight” rating in a research note on Monday, July 8th. Two research analysts have rated the stock with a sell rating, three have given a hold rating and eleven have assigned a buy rating to the company. The company currently has a consensus rating of “Buy” and a consensus target price of $73.36.
NASDAQ CERN traded up $0.37 on Thursday, hitting $69.79. 36,735 shares of the stock traded hands, compared to its average volume of 2,410,672. The company has a 50-day moving average price of $73.01. Cerner Co. has a twelve month low of $48.78 and a twelve month high of $76.47. The stock has a market capitalization of $22.36 billion, a P/E ratio of 31.50, a P/E/G ratio of 2.01 and a beta of 0.92. The company has a debt-to-equity ratio of 0.22, a current ratio of 2.52 and a quick ratio of 2.50.
Cerner (NASDAQ:CERN) last announced its quarterly earnings data on Wednesday, July 24th. The company reported $0.60 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.58 by $0.02. Cerner had a return on equity of 15.14% and a net margin of 10.75%. The firm had revenue of $1.43 billion for the quarter, compared to analysts’ expectations of $1.44 billion. During the same quarter in the prior year, the firm posted $0.62 earnings per share. Cerner’s revenue for the quarter was up 4.6% compared to the same quarter last year. Research analysts expect that Cerner Co. will post 2.43 earnings per share for the current year.
The company also recently disclosed a special dividend, which was paid on Friday, July 26th. Shareholders of record on Tuesday, June 18th were paid a dividend of $0.18 per share. The ex-dividend date was Monday, June 17th. Cerner’s payout ratio is currently 32.58%.
Cerner Company Profile
Cerner Corporation provides health care information technology solutions and tech-enabled services in the United States and internationally. The company offers Cerner Millennium architecture, a person-centric computing framework, which includes clinical, financial, and management information systems that allow providers to access an individual's electronic health record (EHR) at the point of care, and organizes and delivers information for physicians, nurses, laboratory technicians, pharmacists, front- and back-office professionals, and consumers.
Featured Article: Short Selling
Want to see what other hedge funds are holding CERN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cerner Co. (NASDAQ:CERN).
Receive News & Ratings for Cerner Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerner and related companies with MarketBeat.com's FREE daily email newsletter.